Quantcast
Last updated on April 24, 2014 at 16:36 EDT

Calgary Scientific Expands Its FDA-Cleared List, Now Adding Vessel Analysis Capabilities to the Growing List of Advanced Clinical Tools Cleared for Diagnostic Use

June 6, 2012

CALGARY, Alberta, June 6, 2012 /PRNewswire/ — Calgary Scientific Inc. has received clearance from the U.S. Food and Drug Administration (FDA) to market its industry-leading ResolutionMD(TM) Web 2.9 Vessel Analysis module for post-processing diagnostic review and analysis of patient CT and MRI scans. The recently approved module will allow physicians, technologists and surgeons to review, edit, analyze and report findings of vascular anatomy across all applicable specialties. Having the ability to use these tools over the Web brings added value as physicians can access images from home computers and laptops, providing freedom to work anywhere, even when an advanced clinical application or analysis is needed.

“ResolutionMD(TM) Vessel Analysis enables our technologists to efficiently prepare sophisticated CT and MR vascular studies for our hospital clients,” says Dr. Robert Falk, Medical Director, 3DR Laboratories, LLC. “The tools are easy and intuitive to use, and let us quickly isolate vessels for visualization and measurements. The browser-based client provides the ultimate accessibility, not only for our technologists to prepare cases for interpretation, but also for our customer hospitals and physicians.”

“We believe in the rigor of the FDA clearance process and are proud to have another product receive this significant regulatory approval,” says Kyle Peterson, Director of Government and Regulatory Affairs for Calgary Scientific. “Calgary Scientific will continue to aggressively pursue clearances from the FDA and are already working towards growing our cleared platforms and extending the clearance to other product functionality.”

About Calgary Scientific Inc.

Calgary Scientific is dedicated to providing advanced web, mobility, and multi-party collaboration enablement platform technology, as well as advanced visualization solutions to industries looking for secure access and use of their data or graphics-intensive applications, while using their existing systems. All of these products demonstrate a leading-edge web and mobile enablement capability made possible with the unique power of PureWeb®. Calgary Scientific aims to be the premier leader and provider of truly accessible, advanced visualization solutions, in the medical imaging market, as well as the industry leaders in advanced web, mobility, and collaboration enablement technologies. For more information on Calgary Scientific, go to http://www.calgaryscientific.com or http://www.getpureweb.com.

Press Contact:

Jenn Poole
Calgary Scientific
Marketing Communications
Jenn.Poole@calgaryscientific.com
(+1) 403.608.5228

Investor contact:

Byron Osing
Calgary Scientific
CEO and Chair
Byron.Osing@calgaryscientific.com
(+1) 403.767.7959

Calgary Scientific Inc., ResolutionMD, PureWeb and the Calgary Scientific logo are trademarks of Calgary Scientific. All other third-party company names and products are for identification purposes only and may be trademarks of their respective owners.

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE Calgary Scientific Inc.


Source: PR Newswire